SAN DIEGO, Dec. 4, 2025 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme), announced today that a German court has granted its request for a preliminary injunction ordering Merck to refrain from distributing and offering Keytruda SC in Germany. The Munich Regional…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
